Fedwatch: How Few i...
Health Care: Drugs
Amgen Inc (AMGN: NASDAQ)
$101.50 2.42 | 2.44%
06/18/13 - 04:00 PM ET
Latest Dividend:0.47
Latest Dividend Yield:1.93%
Dividend Ex-Date:05/14/13
Price Earnings Ratio:16.46
Price Earnings Comparisons:
| AMGN | Sector Avg. | S&P 500 |
|---|---|---|
| 16.46 | 16.50 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 7.92 | 38.98 | 78.72 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 10.80 | 0.18 | 0.06 |
| Net Income | 18.00 | -0.06 | -0.02 |
| EPS | 36.60 | 0.24 | 0.07 |
Earnings for AMGN:
| EBITDA | 6.96B |
| REVENUE | 17.27B |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $1.68 | $1.73 | $7.20 | $8.22 |
| Number of Analysts | 4 | 4 | 4 | 4 |
| High Estimate | $1.72 | $1.80 | $7.25 | $8.49 |
| Low Estimate | $1.65 | $1.70 | $7.16 | $7.80 |
| Prior Year | $1.82 | $1.67 | $6.45 | $7.20 |
| Growth Rate (Year over Year) | -7.69% | 3.44% | 11.55% | 14.28% |
Portfolios with AMGN
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorHigh Volume Technicals for ...
- UserDividend Stocks
- ContributorTechnical Setups for the We...
- ContributorTechnical Setups for the We...
- UserStevo
- ContributorPotential Dividend Hikes fo...
- UserMike Fatah's Mega Stock Por...
- UserGFNN Stockdiagnostics 23
- UserLong Term Stock Picks
Latest AMGN Headlines from TheStreet
- 5 Stocks Raising The Drugs Industry Higher 06.17.13 | 01:06 pm
- Amgen Inc (AMGN): Today's Featured Drugs Laggard 06.14.13 | 05:06 pm
- Cramer's 'Mad Money' Recap: Profiting From Panic 06.11.13 | 08:06 pm
- 5 Drugs Stocks Dragging The Industry Down 06.10.13 | 01:06 pm
- 'Mad Money' Lightning Round: Amgen's Not a Fave 06.06.13 | 06:06 am
- Cramer's 'Mad Money' Recap: Profit While You Can 06.05.13 | 08:06 pm
- CELG, AMGN, GILD, JNJ And PFE, Pushing Drugs Industry Downward 06.04.13 | 01:06 pm
- Amgen Inc (AMGN): Today's Featured Drugs Laggard 06.03.13 | 05:06 pm
- ASCO '13: Amgen's Cancer-Killing Virus Shows Skin-Cancer Survival Trend 06.01.13 | 07:06 am
- Small-Cap Biotechs Pursue IPOs Fastest in Decade 05.29.13 | 12:05 pm
Press Releases for AMGN
- FDA Approves Amgen's XGEVA® (denosumab) For The Treatment Of Giant Cell Tumor Of Bone - PR Newswire 06.13.13 | 03:06 pm
- Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer - PR Newswire 06.12.13 | 09:06 am
- Amgen To Present At The Goldman Sachs 34th Annual Global Healthcare Conference - PR Newswire 06.06.13 | 04:06 pm
- Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma - PR Newswire 06.01.13 | 07:06 am
- Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting - PR Newswire 05.29.13 | 04:05 pm
- Amgen To Present At The Deutsche Bank 38th Annual Healthcare Conference - PR Newswire 05.23.13 | 05:05 pm
- Amgen Announces Voting Results Of Annual Meeting Of Stockholders - PR Newswire 05.22.13 | 05:05 pm
- Amgen To Present At The UBS Global Life Sciences Conference - PR Newswire 05.16.13 | 04:05 pm
- Amgen Highlights Data To Be Presented At American Society Of Clinical Oncology Annual Meeting - PR Newswire 05.15.13 | 06:05 pm
- Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China - PR Newswire 05.09.13 | 04:05 pm
Partner Headlines for AMGN
- Big Cap Leaders Slide But Show Little Technical Damage - Investor's Business Daily 04.15.13 | 07:04 pm
- Pockets of Strength In Top Groups, Few Leaders Basing - Investor's Business Daily 04.15.13 | 06:04 pm
- Stocks End With Mild Losses; Nasdaq Rises 2.8% For Week - Investor's Business Daily 04.12.13 | 05:04 pm
- Can New Psoriasis Drugs Scratch Investors' Itch? - Investor's Business Daily 04.04.13 | 01:04 pm
- Cree, Seagate, Sandisk: Why Richie Freeman Likes Them - Investor's Business Daily 04.02.13 | 06:04 pm
- Biotech Breakout Boosting ETFs - Benzinga 03.28.13 | 03:03 pm
- Wall St rises as Fed reaffirms policies - Financial Times 03.20.13 | 08:03 pm
- Celgene Leads Handful Of Big Cap Stocks To New Highs - Investor's Business Daily 03.11.13 | 06:03 pm
- When To Add A New Full Position In A Good Stock - Investor's Business Daily 03.11.13 | 06:03 pm
- PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 01, 2013 - NASDAQ 02.27.13 | 02:02 pm
